APOA5 Antikörper (truncated)

Produktnummer ABIN2464012

Produktdetails anti-APOA5 Antikörper

Target: APOA5 (Apolipoprotein A-V (APOA5))

Bindungsspezifität: truncated

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser APOA5 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA

Immunogen: Ni-NTA purified truncated recombinant human APOA5 expressed in E. Coli strain BL21 (DE3).

Klon: 4H8H8E2(c)

Isotyp: IgG1

Anwendungsinformationen

Applikationshinweise: Western Blot, ELISA.
Dilution:
Western Blot:1:500 - 1,000
ELISA:Determining optimal working dilutions by titration test.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Buffer: Ascitic fluid containing 0.03 % sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

Lagerung: -20 °C

Informationen zur Lagerung: Apoa5(bd) monoclonal antibody can be stored at -20 °C, stable for one year.

Details zu APOA5

Target: APOA5 (Apolipoprotein A-V (APOA5))

Andere Bezeichnung: Apoa5 (APOA5 Produkte)

Synonyme: APOAV antikoerper, RAP3 antikoerper, 1300007O05Rik antikoerper, Apoav antikoerper, apo-AV antikoerper, apoA-V antikoerper, APOA5 antikoerper, MGC140487 antikoerper, rap3 antikoerper, apoav antikoerper, apoa-v antikoerper, apolipoprotein A5 antikoerper, apolipoprotein A-V antikoerper, apolipoprotein A5 L homeolog antikoerper, APOA5 antikoerper, Apoa5 antikoerper, apoa5.L antikoerper, apoa5 antikoerper

Hintergrund: Apolipoprotein A5 (ApoA5) is fast gaining attention as a key regulator of serum triglyceride concentrations. An ApoA5 mouse knock-out model produced an approximately four fold increase in serum triglyc erides, whereas a knock-in model with human ApoA5 produced 50 70 % lower concentrations of mouse serum triglycerides. In addition, peroxisome proliferator-activated receptor-_ agonists, which are used clinically to lower serum triglyceride concentrations, cause increased ApoA5 mRNA expression. Recently, it was demonstrated that ApoA5 is present in human serum detected by polyclonal antibodies against both the NH2 and COOH termini, although at much lower concentration than other apolipoproteins.

Gen-ID: 116519

UniProt: Q6Q788

Pathways: Regulation of Lipid Metabolism by PPARalpha, Lipid Metabolism